This training provides a comprehensive overview of the requirements and latest updates related to Notified Body Opinions for single integral drug/device combination products under art. 117 of the Regulation (EU) 2017/745 on medical devices (MDR).
Given the end of the implementation period for the MDR on 26 May 2021, the course will present complementary perspectives from the pharmaceutical industry, device manufacturer, and Notified Body on the changes for integral drug/device combination products related to art. 117 MDR.
Check out the program here
